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Conclusions: Contrary to our hypothesis, orthostatic venous pooling was
not accentuated in diabetics with hyperadrenergic OH+. Their disease is
probably due to end organ resistance to plasma norepinephrine.
output and blood pressure. Based on upright plasma norepinephrine (UPNE).
patients were classified as: hyperadrenergic if UPNE is >55B pglml, hypoad-
renergic if UPNE <495 and normal adrenergic response if 494 >UPNE <558.
Within each group, orthostatic hypotension OH + was defined as a decrease
in systolic blood pressure of >20 mmHg during tilt.
Results:
HyperAdr HypoAdr Norm Adr
OH+ OH- OH+ OH- OH+ OH-
n 12 6 15 10 4 7
t.SBP mmHg -55±25 -12±6' -53±23 -8±8' -62±11 2±24'
t.HR BPM 6±9 7±7 13±18 4±6 13±18 11±8
t.TPR U.M2 0.8±7 12±14 04±7 4±8 4±4 11±8
t.CPVff8V% -2±1 -2.5±3 -1±3 -1±2 -2±1 -2±3
t.PNE Pg/ml 456±512 369±198 49±80t 98±65t 284±33 238±114
x ± SD 'p < 0.0001 YS OH+ (HyperA, HypoA & Norm A). t P < 0.01 YS OH+ (HyperA).
TPR = total peripheral resistance
platelet surface receptor changes is unknown. In addition, further clarifica-
tion of the changes in hemostatic and rheological factors that can promote
platelet aggregation and that may occur upon standing, are required.
Methods and Results: We therefore investigated the effect of arising in the
morning on whole blood impedance aggregometry in 12 normal subjects and
simultaneously measured platelet activation directly by using whole blood
flow cytometry (n = 5). Aggregometry was completed and antibodies were
added within 10 mins of blood withdrawal. Hemodynamic changes (n = 12).
catecholamines (n = 6). fibrinogen (n = 6), platelet count and hematocrit(n =
8) were also measured. Platelet aggregation to ADP and collagen increased
by 75% (p < 0.01) and 32% (p < 0.01) respectively. However, this was not
associated with evidence of activation using flow cytometry. Six markers
(GPlb, P-selectin, activated GPllb-lIla, GPIV, fibrinogen and vWF) tested with
10 antibodies showed no change in either percent positivity or flourescence
intensity. Platelet count and fibrinogen levels increased by 14% (p < 0.01)
and 12% (p < 0.04) respectively which was partly due to hemoconcentra-
tion (hematocrit increased by 7%, p < 0.01). Heart rate and norepinephrine
levels significantly increased by 20% (p < 0.02) and 163% (p < 0.01) respec-
tively.
Conclusions: The observed increase in whole blood platelet aggregation
on arousal and standing in the morning is not accompanied by activation-
dependent platelet surface receptor changes. Thus changes in rheologi-
cal and hemostatic factors, such as increases in platelet count and fibrino-
gen level, together with indirect effects of increases in catecholamine lev-
els may playa more important role in promoting platelet aggregation upon
standing.
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Is the INR an Adequate Corrective Factor for
the Range of Thromboplastins Utilized in North
America?
Alan K. Jacobson, Steven W. Hildebrand, James C. Westengard, Chandra Hart,
Anita McManus, Ramdas G. Pai, David R. Ferry, J. Thomas Heywood. Loma Linda
VAMC & Lama Unda UniversitY- Lama Unda, CA
For a given intensity of anticoagulant therapy the Prothrombin Time Ratio
(PTR) shows wide variability when measured with different thromboplastin
reagents due to differing sensitivities of the commercially available thrombo-
plastins as reflected in differences in the International Sensitivity Index (lSI)
values for each reagent. The International Normalized Ratio (INR) is used to
correct for this variation. We investigated the variability of INR obtained with
11 different thromboplastins from 4 different manufacturers using a single
venipuncture sample from each of 49 unselected patients. The lSI values of
the thromboplastins ranged from 1.0 to 2.81 and all analyses were performed
on a MLA 700 instrument.
Results: For any individual thromboplastin the coefficient of variation (CV)
was verylow-1.6t04.6%. However, when comparing INR values from alill
thromboplastins the CV was 19%, which was a significant improvement over
the CV for PTR of 29%, (p < 0.005) but still high enough to allow for clinically
significant differences as demonstrated by the following confidence ranges:
INR 95% Confidence Range CV
lower limit upper limit
1.6 1.2 20 13%
24 1.7 31 15%
37 20 53 23%
4.7 22 73 27%
The CV and the standard deviation were directly related to the INR with
higher variability at higher levels of anticoagulant intensity.
Conclusion: While the INR offers a significant reduction in variance as com-
pared to the PTR, it is suboptimal for the range of thromboplastins available
in North America, and can result in clinically significant variation when com-
paring INR results between institutions utilizing different thromboplastins,
especially at higher intensities of anticoagulation.
Is Diabetic "Hyperadrenergic Orthostatic
Hypotension" due to End Organ Resistance to
Catecholamines?
Riad R. Hajjar, Abbas Shehadeh, Abdelkarim Waness, Emmanuel L. Bravo, Fetnat
M. Fouad-Tarazi. The Cleveland Clinic Foundation, Cleveland, OH
It has been previously reported that orthostatic hypotension occurs in some
diabetics despite markedly increased standing plasma norepinephrine. The
mechanism for this response remains unclear. We hypothesized that this
"hyperadrenergic response" is triggered by accentuated postural venous
translocation of blood volume (venous pooling). We assessed the hemody-
namic (99m Tc-RBC) and catecholamine responses to upright posture in 54
diabetic patients (30 M: 24 F, age 57.5 ± 13 yrs). Venous translocation was
defined by the ratio of cardiopulmonary volume (CPV) to total blood volume
(TBV, RISA method). Total peripheral resistance was calculated from cardiac
F.H. Shiffman, R.M. Prewitt, U. Schick, J. Ducas. Health Sciences Centre, University
of Manitoba, Winnipeg, Manitoba, Canada
Nitric oxide (NO) has been shown to be effective in reducing pulmonary artery
pressure in many forms of pulmonary hypertension. While the intracellular
mechanism of action is known, the pulmonary hemodynamic effects are not
fully elucidated. This study examined the effects of inhaled NO on the pul-
monary vascular pressure-flow (P-O) relationship in a canine model of pul-
monary embolism. According to P-O theory, the slope of the P-O plot defines
the incremental vascular resistance (unit pressure change per unit change in
flow) and the extrapolated pressure intercept defines the effective vascular
outflow pressure. Six dogs were embolized with autologous blood clot to
create pulmonary hypertension complicated by a low cardiac output state.
To define the P-O plot, multiple mean pulmonary artery pressure (PAP) vs
cardiac output (COl coordinates were obtained pre and post embolization,
and before, during and after treatment with nitric oxide (180-200 ppm). The
PAP-CO coordinates were obtained by varying flow through systemic arteri-
ovenous fistulas. Embolization increased PAP (14.8 ± 1.2 to 34.6 ± 4.6; P <
0.001) and decreased CO (3.45 ± 0.63 to 2.25 ± 0.43; P < 005). All PAP-CO
relationships were well described by a linear equation (mean r value 0.921
± 0.029). Both the slope and intercept of the PAP-CO plot increased with
embolization, (1.41 ± 0.09 to 3.51 ± 1.22; P < 0.05 and 9.9 ± 1.1 to 28.0 ±
6.5; p < 0.005 respectively). NO significantly improved pulmonary hemody-
namics. The intercept of the PAP-CO plot decreased from the initial control
of 28.0 mmHg to 22.5 mmHg (p < 0.05), and following discontinuation of
the NO, increased to 26.2 mmHg (p < 0.05). The slope was not affected.
Furthermore, NO did not affect systemic hemodynamics. In this model of
pulmonary embolism, the increase in PAP is predominantly explained by an
increase in the extrapolated pressure intercept (PI) and NO selectively im-
proved pulmonary hemodynamics by decreasing PI. Conclusion: Based on
previous work, it is most likely that the decrease in PI represents a localized
decrease in pulmonary vascular tone upstream from the capillary bed.
Effect of Pravastatin on Abdominal Aorta and
Carotid Wall Thickness in Dyslipidemia
Giuseppe Gullace, Franco Ruffa. Centro Cardiologia Preventiva e Riabilitativa, USSL;
Lecco. Bosisio Parim: Italy
We studied 85 pts (45 female, 40 male, aged 55 ± 5 yrs) with familiar dys-
lipidemia, to assess the effect of pravastatin 15 mg daily orally administered
on abdominal aorta (M) and carotid (C) wall thickness (WT) compared to
variation of total cholesterol ITCH) and LDL plasma levels. All underwent a 3
months period of dietary fat restriction and included in the study when TCH
was still >240 mg/dl after this period. M-WT and M-WT corrected by the ra-
dius (M-WTIr) were obtained using echography with a 3.5 MHz transducer,
whereas C-WT and intima-media thickness (IMT) were obtained using a 5
MHz one. Media wall thickness (MWT = eWT - IMT) was also considered.
Measurements were detected on basal and after 4.5 ± 1.2 months of ther-
apy. The following results were obtained and compared by means of paired
data t test:
